Free Trial
NASDAQ:QDEL

QuidelOrtho (QDEL) Stock Price, News & Analysis

QuidelOrtho logo
$26.40 -0.99 (-3.61%)
As of 10:22 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About QuidelOrtho Stock (NASDAQ:QDEL)

Key Stats

Today's Range
$26.42
$27.29
50-Day Range
$25.30
$32.57
52-Week Range
$23.77
$49.45
Volume
52,961 shs
Average Volume
1.29 million shs
Market Capitalization
$1.79 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$44.33
Consensus Rating
Hold

Company Overview

QuidelOrtho Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
89th Percentile Overall Score

QDEL MarketRank™: 

QuidelOrtho scored higher than 89% of companies evaluated by MarketBeat, and ranked 118th out of 936 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    QuidelOrtho has received a consensus rating of Hold. The company's average rating score is 2.43, and is based on 4 buy ratings, 2 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    QuidelOrtho has only been the subject of 2 research reports in the past 90 days.

  • Read more about QuidelOrtho's stock forecast and price target.
  • Earnings Growth

    Earnings for QuidelOrtho are expected to grow by 39.57% in the coming year, from $2.30 to $3.21 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of QuidelOrtho is -5.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of QuidelOrtho is -5.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    QuidelOrtho has a P/B Ratio of 0.62. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about QuidelOrtho's valuation and earnings.
  • Percentage of Shares Shorted

    8.75% of the float of QuidelOrtho has been sold short.
  • Short Interest Ratio / Days to Cover

    QuidelOrtho has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in QuidelOrtho has recently increased by 44.23%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    QuidelOrtho does not currently pay a dividend.

  • Dividend Growth

    QuidelOrtho does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    8.75% of the float of QuidelOrtho has been sold short.
  • Short Interest Ratio / Days to Cover

    QuidelOrtho has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in QuidelOrtho has recently increased by 44.23%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    QuidelOrtho has a news sentiment score of 0.45. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.08 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 8 news articles for QuidelOrtho this week, compared to 7 articles on an average week.
  • MarketBeat Follows

    2 people have added QuidelOrtho to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, QuidelOrtho insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.79% of the stock of QuidelOrtho is held by insiders.

  • Percentage Held by Institutions

    99.00% of the stock of QuidelOrtho is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about QuidelOrtho's insider trading history.
Receive QDEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for QuidelOrtho and its competitors with MarketBeat's FREE daily newsletter.

QDEL Stock News Headlines

AI Frenzy Could Send ‘EarnPhone’ Soaring
The hidden fuel behind AI? Your phone. Billions of data points — from your clicks, swipes, scrolls, and searches — are feeding the next wave of AI innovation. Big Tech is harvesting it. Mode Mobile is giving it back to you. They are creating a user-powered data economy that shares the upside, and +50M users have already generated +$325M in earnings. This isn't a theory… Mode’s 32,481% revenue growth from 2019-2022 landed them the #1 spot on Deloitte’s 2023 list of fastest growing companies in software, and they’ve secured the Nasdaq ticker $MODE ahead of a potential IPO. The offering could close any moment now. AI breakthroughs are everywhere, but these models need your data to survive. Invest in the company that allows you to share in the profits from yours.
See More Headlines

QDEL Stock Analysis - Frequently Asked Questions

QuidelOrtho's stock was trading at $44.55 at the beginning of the year. Since then, QDEL shares have decreased by 38.5% and is now trading at $27.39.

QuidelOrtho Corporation (NASDAQ:QDEL) posted its earnings results on Wednesday, May, 7th. The company reported $0.74 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.61 by $0.13. The company's revenue was down 2.6% on a year-over-year basis.
Read the conference call transcript
.

QuidelOrtho's top institutional investors include Assenagon Asset Management S.A. (1.39%), Gagnon Securities LLC (0.11%), Moody National Bank Trust Division (0.08%) and CWM LLC (0.06%). Insiders that own company stock include Brian J Blaser, Joseph M Busky and Carlyle Group Inc.
View institutional ownership trends
.

Shares of QDEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that QuidelOrtho investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), PayPal (PYPL), Salesforce (CRM) and CrowdStrike (CRWD).

Company Calendar

Last Earnings
5/07/2025
Today
7/28/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:QDEL
CIK
353569
Employees
6,600
Year Founded
1979

Price Target and Rating

High Price Target
$61.00
Low Price Target
$25.00
Potential Upside/Downside
+61.9%
Consensus Rating
Hold
Rating Score (0-4)
2.43
Research Coverage
7 Analysts

Profitability

EPS (Trailing Twelve Months)
($4.97)
Trailing P/E Ratio
N/A
Forward P/E Ratio
11.91
P/E Growth
N/A
Net Income
-$2.05 billion
Net Margins
-12.07%
Pretax Margin
-12.35%
Return on Equity
4.71%
Return on Assets
2.21%

Debt

Debt-to-Equity Ratio
0.70
Current Ratio
1.20
Quick Ratio
0.66

Sales & Book Value

Annual Sales
$2.78 billion
Price / Sales
0.67
Cash Flow
$35.57 per share
Price / Cash Flow
0.77
Book Value
$44.38 per share
Price / Book
0.62

Miscellaneous

Outstanding Shares
67,630,000
Free Float
67,092,000
Market Cap
$1.85 billion
Optionable
Optionable
Beta
0.07

Social Links

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:QDEL) was last updated on 7/28/2025 by MarketBeat.com Staff
From Our Partners